Delivery Order SPE2DR25D1053-SPE2DR26FT505
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Temozolomide 250 mg capsules in quantities of five, with a ceiling value of $1,043.74. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location and completed by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 14 capsules of the drug Temozolomide 100 mg. The $1,337.54 contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. This delivery order is part of a larger $999,999,999.00...
- The Defense Logistics Agency awarded a $100,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 5,000 Temozolomide 5 mg capsules to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 28, 2023 to fulfill requirements under the agency's pharmaceutical supply vehicle. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $143,100 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of temozolomide 20 mg capsules. Under this order, AmerisourceBergen will deliver 5 packages of the chemotherapy drug to a facility in Conshohocken, Pennsylvania by September 21, 2023 to support the Department of Defense's medical countermeasures programs. As a top 50 Defense Logistics Agency contractor, AmerisourceBergen regularly provides pharmaceuticals and...
- The Defense Logistics Agency awarded a $2,253.38 firm fixed price delivery order to Amerisourcebergen Drug Corporation for temozolomide 140 mg capsules. Under this order, Amerisourcebergen will deliver 5 units of the specified chemotherapy drug to a facility located in Conshohocken, Pennsylvania by June 26, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations, suggesting this procurement supports medical supplies for DOD facilities and personnel....
- The Defense Logistics Agency awarded a $199,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for temozolomide 100 mg capsules. The delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place in Conshohocken, Pennsylvania over a three day period concluding on July 3, 2023. No subcontractors or set aside designations were identified. The temozolomide...
- The Defense Logistics Agency awarded a $8,896.41 delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price delivery order, issued without set-aside designation, was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single shipment of this oncology medication through AmerisourceBergen's established federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trodelvy 180 mg vials, a cancer treatment medication. This firm fixed-price delivery order, valued at $15,974.30, is scheduled for completion by August 7, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT505Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Temozolomide 140 mg capsules (14-count units) with a ceiling value of $3,561.36. This is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. Temozolomide is a critical chemotherapy agent used in cancer treatment protocols, particularly for brain tumors and melanomas, making this procurement essential for supporting military and veteran healthcare systems. As a major pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen has demonstrated capability to fulfill diverse pharmaceutical requirements through its extensive portfolio of competitive awards with the Defense Logistics Agency. This delivery order exemplifies the company's role as a key vendor within the military medical supply chain, providing specialized oncology medications alongside its broader range of pharmaceutical products and medical supplies to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/31/25 |